Berkley W R Corp Increases Position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)

Berkley W R Corp raised its position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) by 69.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 319,460 shares of the company’s stock after purchasing an additional 130,598 shares during the quarter. Berkley W R Corp owned about 4.24% of ARYA Sciences Acquisition Corp IV worth $3,600,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Virtu Financial LLC acquired a new position in ARYA Sciences Acquisition Corp IV in the 4th quarter valued at about $204,000. K2 Principal Fund L.P. acquired a new position in shares of ARYA Sciences Acquisition Corp IV in the 1st quarter worth approximately $441,000. Affinity Asset Advisors LLC acquired a new position in shares of ARYA Sciences Acquisition Corp IV in the 1st quarter worth approximately $1,505,000. Hsbc Holdings PLC acquired a new position in shares of ARYA Sciences Acquisition Corp IV in the 4th quarter worth approximately $1,630,000. Finally, Mizuho Securities USA LLC lifted its holdings in shares of ARYA Sciences Acquisition Corp IV by 218.7% in the 4th quarter. Mizuho Securities USA LLC now owns 332,532 shares of the company’s stock worth $3,625,000 after acquiring an additional 228,187 shares during the last quarter. 48.08% of the stock is currently owned by institutional investors and hedge funds.

ARYA Sciences Acquisition Corp IV Stock Performance

Shares of ARYD stock traded down $0.89 during trading hours on Monday, hitting $9.88. The company had a trading volume of 3,325 shares, compared to its average volume of 39,599. ARYA Sciences Acquisition Corp IV has a fifty-two week low of $9.88 and a fifty-two week high of $11.57. The company’s fifty day moving average is $11.40 and its 200 day moving average is $11.29.

ARYA Sciences Acquisition Corp IV Profile

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.